Supplementary Table 2 from Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma
收藏Figshare2024-07-15 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Supplementary_Table_2_from_Tumor-Immune_Signatures_of_Treatment_Resistance_to_Brentuximab_Vedotin_with_Ipilimumab_and_or_Nivolumab_in_Hodgkin_Lymphoma/28688344
下载链接
链接失效反馈官方服务：
资源简介：
Experimental data userd in the article including Olink, CyTOF populational frequencies, Serology and TCRseq beta chain.
创建时间：
2024-07-15
